Skip to main content
. 2023 Sep 3;12(17):5731. doi: 10.3390/jcm12175731

Table 2.

Mean values ± SD of evaluated clinical outcomes measured at baseline and after 2 weeks of crenotherapy in a total cohort of females and males.

Group Females Males p Value
Pain (VAS-score) before 2.8 ± 1.0 1.8 ± 1.1 0.004
after 1.7 ± 1.2 1.0 ± 0.97 0.058
p value 0.001 0.0003
Morning Stiffness (VAS-score) before 2.6 ± 1.4 1.0 ± 0.8 0.008
after 1.7 ± 1.4 0.5 ± 0.8 0.042
p value 0.002 0.04
Itch (VAS-score) before 1.8 ± 1.5 1.9 ± 1.8 0.876
after 0.2 ± 0.4 1.0 ± 1.2 0.030
p value 0.003 0.001